|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 20 of 25
| Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | | article | Nomoto, Hiroshi; Furusawa, Sho; Nakamura, Akinobu; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Sakuma, Ichiro; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Miya, Aika; Kameda, Hiraku; Cho, Kyu Yong; Atsumi, Tatsuya; Miyoshi, Hideaki | Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes : protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 st | - | BMJ Open | - | May-2022 |
| article | Kamoshima, Hikaru; Nomoto, Hiroshi; Yamashita, Kumiko; Takahashi, Yuka; Tsuchida, Kazuhisa; Kuwabara, Saki; Miya, Aika; Cho, Kyu Yong; Kameda, Hiraku; Nakamura, Akinobu; Atsumi, Tatsuya; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Ono, Yuri; Miyoshi, Hideaki | Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes? | - | Endocrine journal | - | 28-Jan-2022 |
| article | Hashimoto-Kameda, Reina; Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Omori, Kazuno; Nagai, So; Edagawa, Sachiko; Kawata, Shinichiro; Takeuchi, Jun; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study) | - | Diabetes research and clinical practice | - | Oct-2021 |
| article | Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Omori, Kazuno; Tsuchida, Kazuhisa; Miya, Aika; Shigesawa, Ikumi; Tsuchida, Kenichi; Yanagiya, Shingo; Kameda, Hiraku; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Nishimoto, Naoki; Atsumi, Tatsuya; Miyoshi, Hideaki | Improved Time in Range and Postprandial Hyperglycemia with Canagliflozin in Combination with Teneligliptin : Secondary Analyses of the CALMER study | - | Journal of Diabetes Investigation | - | 10-Aug-2021 |
| article | Miya, Aika; Nakamura, Akinobu; Cho, Kyu Yong; Kawata, Shinichiro; Nomoto, Hiroshi; Nagai, So; Sugawara, Hajime; Taneda, Shinji; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Takeuchi, Jun; Aoki, Shin; Kurihara, Yoshio; Atsumi, Tatsuya; Miyoshi, Hideaki | Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients type 2 diabetes treated with canagliflozin plus teneligliptin | - | Journal of Diabetes Investigation | - | 10-Aug-2021 |
| article | Cho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Yamamoto, Kohei; Nomoto, Hiroshi; Kameda, Hiraku; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone | - | Journal of Diabetes Investigation | - | 8-Jul-2021 |
| article | Nomoto, Hiroshi; Oba-Yamamoto, Chiho; Takahashi, Yuka; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Kameda, Hiraku; Cho, Kyu Yong; Nakamura, Akinobu; Atsumi, Tatsuya; Miyoshi, Hideaki | Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes : Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study) | - | Diabetes Therapy | - | Mar-2021 |
| article | Chiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Sodium-glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes | - | Journal of diabetes investigation | - | Feb-2021 |
| article | Chiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Sodium–glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes | - | Journal of Diabetes Investigation | - | Feb-2021 |
| article | Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation : An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study) | - | Diabetes, Obesity and Metabolism | - | Mar-2020 |
| article | Kameda, Reina; Nomoto, Hiroshi; Cho, Kyu Yong; Kawata, Shinichiro; Omori, Kazuno; Takeuchi, Jun; Nagai, So; Kurihara, Yoshio; Aoki, Shin; Nakamura, Akinobu; Atsumi, Tatsuya; Miyoshi, Hideaki | Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes : protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study | - | BMJ Open | - | Feb-2020 |
| article | Nakamura, Akinobu; Miyoshi, Hideaki; Kameda, Hiraku; Yamashita, Kumiko; Kurihara, Yoshio | Impact of sodium-glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria | - | Diabetology and metabolic syndrome | - | 10-Jan-2020 |
| article | Miyoshi, Hideaki; Kameda, Hiraku; Yamashita, Kumiko; Nakamura, Akinobu; Kurihara, Yoshio | Protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes | - | Journal of diabetes investigation | - | Nov-2019 |
| article | Takase, Takahiro; Nakamura, Akinobu; Yamamoto, Chiho; Nomoto, Hiroshi; Miya, Aika; Dannoura, Midori; Cho, Kyu Yong; Kurihara, Yoshio; Manda, Naoki; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes : A randomized controlled trial | - | Journal of Diabetes Investigation | - | May-2019 |
| article | Omori, Kazuno; Nomoto, Hiroshi; Nakamura, Akinobu; Takase, Takahiro; Cho, Kyu Yong; Ono, Kota; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide : A randomized controlled trial of repaglinide vs sulfonylurea | - | Journal of Diabetes Investigation | - | Mar-2019 |
| article | Takahashi, Kiyohiko; Cho, Kyu Yong; Nakamura, Akinobu; Miya, Aika; Miyoshi, Arina; Yamamoto, Chiho; Nomoto, Hiroshi; Niwa, Hirokatsu; Takahashi, Kiyohito; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Ito, Yoichi M; Atsumi, Tatsuya; Miyoshi, Hideaki | Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes | - | Journal of Diabetes Investigation | - | Mar-2019 |
| article | Cho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus : An open-label, prospective, randomized, parallel-group comparison trial | - | Diabetes, Obesity and Metabolism | - | Mar-2019 |
| article | Cho, Kyu Yong; Nakamura, Akinobu; Oba-Yamamoto, Chiho; Tsuchida, Kazuhisa; Yanagiya, Shingo; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus : Randomized Controlled Trial | - | Diabetes & Metabolism Journal | - | 2019 |
| article | Oita, Mayuko; Miyoshi, Hideaki; Ono, Kota; Nakamura, Akinobu; Cho, Kyu Yong; Nomoto, Hiroshi; Yamamoto, Kohei; Omori, Kazuno; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya | Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes : Randomized controlled study | - | Endocrine Journal | - | Feb-2018 |
| article | Miya, Aika; Nakamura, Akinobu; Miyoshi, Hideaki; Cho, Kyu Yong; Nagai, So; Kurihara, Yoshio; Aoki, Shin; Taguri, Masataka; Terauchi, Yasuo; Atsumi, Tatsuya | Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy : A randomized controlled trial | - | Journal of Diabetes Investigation | - | Jan-2018 |
Showing results 1 to 20 of 25
|
